Clinical trial
Randomized Double-blind Placebo-controlled Study of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis
NCT01121016 is registered in ClinicalTrials.gov with Guangzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-blind Placebo-controlled Study of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis
- Lead sponsor
- Guangzhou Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- June 30, 2011
- Enrollment
- 63 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nonasthmatic eosinophilic bronchitis